BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24879062)

  • 21. IL-10
    Jiang Y; Yang M; Sun X; Chen X; Ma M; Yin X; Qian S; Zhang Z; Fu Y; Liu J; Han X; Xu J; Shang H
    BMC Infect Dis; 2018 Feb; 18(1):80. PubMed ID: 29439673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein tyrosine phosphorylation and p56lck modification in IL-2 or phorbol ester-activated human natural killer cells.
    Einspahr KJ; Abraham RT; Dick CJ; Leibson PJ
    J Immunol; 1990 Sep; 145(5):1490-7. PubMed ID: 1696599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.
    Wilson EB; El-Jawhari JJ; Neilson AL; Hall GD; Melcher AA; Meade JL; Cook GP
    PLoS One; 2011; 6(9):e22842. PubMed ID: 21909397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of NK cell functions by TGF-beta 1.
    Bellone G; Aste-Amezaga M; Trinchieri G; Rodeck U
    J Immunol; 1995 Aug; 155(3):1066-73. PubMed ID: 7636180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells.
    Huntington ND; Xu Y; Nutt SL; Tarlinton DM
    J Exp Med; 2005 May; 201(9):1421-33. PubMed ID: 15867094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells.
    Yu J; Wei M; Becknell B; Trotta R; Liu S; Boyd Z; Jaung MS; Blaser BW; Sun J; Benson DM; Mao H; Yokohama A; Bhatt D; Shen L; Davuluri R; Weinstein M; Marcucci G; Caligiuri MA
    Immunity; 2006 May; 24(5):575-90. PubMed ID: 16713975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blocking transforming growth factor-β signaling pathway augments antitumor effect of adoptive NK-92 cell therapy.
    Yang B; Liu H; Shi W; Wang Z; Sun S; Zhang G; Hu Y; Liu T; Jiao S
    Int Immunopharmacol; 2013 Oct; 17(2):198-204. PubMed ID: 23806302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helioxanthin inhibits interleukin-1 beta-induced MIP-1 beta production by reduction of c-jun expression and binding of the c-jun/CREB1 complex to the AP-1/CRE site of the MIP-1 beta promoter in Huh7 cells.
    Tseng PC; Hsu HC; Janmanchi D; Lin CH; Kuo YH; Chou CK; Yeh SF
    Biochem Pharmacol; 2008 Oct; 76(9):1121-33. PubMed ID: 18789903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Artesunate down-regulates immunosuppression from colorectal cancer Colon26 and RKO cells in vitro by decreasing transforming growth factor β1 and interleukin-10.
    Cui C; Feng H; Shi X; Wang Y; Feng Z; Liu J; Han Z; Fu J; Fu Z; Tong H
    Int Immunopharmacol; 2015 Jul; 27(1):110-21. PubMed ID: 25978851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor-beta inhibits interleukin-12-induced production of interferon-gamma by natural killer cells: a role for transforming growth factor-beta in the regulation of T cell-independent resistance to Toxoplasma gondii.
    Hunter CA; Bermudez L; Beernink H; Waegell W; Remington JS
    Eur J Immunol; 1995 Apr; 25(4):994-1000. PubMed ID: 7737303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of CREB transcription factor in c-fos activation in natural killer cells.
    Ponti C; Gibellini D; Boin F; Melloni E; Manzoli FA; Cocco L; Zauli G; Vitale M
    Eur J Immunol; 2002 Dec; 32(12):3358-65. PubMed ID: 12432566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.
    Ruegemer JJ; Ho SN; Augustine JA; Schlager JW; Bell MP; McKean DJ; Abraham RT
    J Immunol; 1990 Mar; 144(5):1767-76. PubMed ID: 2407783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vav-Rac1-mediated activation of the c-Jun N-terminal kinase/c-Jun/AP-1 pathway plays a major role in stimulation of the distal NFAT site in the interleukin-2 gene promoter.
    Kaminuma O; Deckert M; Elly C; Liu YC; Altman A
    Mol Cell Biol; 2001 May; 21(9):3126-36. PubMed ID: 11287617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming growth factor-beta induced collagenase-3 production in human osteoarthritic chondrocytes is triggered by Smad proteins: cooperation between activator protein-1 and PEA-3 binding sites.
    Tardif G; Reboul P; Dupuis M; Geng C; Duval N; Pelletier JP; Martel-Pelletier J
    J Rheumatol; 2001 Jul; 28(7):1631-9. PubMed ID: 11469472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of transforming growth factor-beta signalling attenuates interleukin (IL)-18 plus IL-2-induced interstitial lung disease in mice.
    Segawa S; Goto D; Yoshiga Y; Sugihara M; Hayashi T; Chino Y; Matsumoto I; Ito S; Sumida T
    Clin Exp Immunol; 2010 Jun; 160(3):394-402. PubMed ID: 20089076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGF-β Down-regulates Apolipoprotein M Expression through the TAK-1-JNK-c-Jun Pathway in HepG2 Cells.
    Ren K; Mo ZC; Liu X; Tang ZL; Jiang Y; Peng XS; Zhang QH; Shi JF; Yi GH
    Lipids; 2017 Feb; 52(2):109-117. PubMed ID: 28039587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Streptococcus pneumoniae induced c-Jun-N-terminal kinase- and AP-1 -dependent IL-8 release by lung epithelial BEAS-2B cells.
    Schmeck B; Moog K; Zahlten J; van Laak V; N'Guessan PD; Opitz B; Rosseau S; Suttorp N; Hippenstiel S
    Respir Res; 2006 Jul; 7(1):98. PubMed ID: 16834785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
    Kasid A; Bell GI; Director EP
    J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-2 and IL-4 stimulate MEK1 expression and contribute to T cell resistance against suppression by TGF-beta and IL-10 in asthma.
    Liang Q; Guo L; Gogate S; Karim Z; Hanifi A; Leung DY; Gorska MM; Alam R
    J Immunol; 2010 Nov; 185(10):5704-13. PubMed ID: 20926789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of natural killer cell activity by transforming growth factor-beta and prostaglandin E2.
    Malygin AM; Meri S; Timonen T
    Scand J Immunol; 1993 Jan; 37(1):71-6. PubMed ID: 8380302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.